Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.40e-21	114	133	19	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	7.49e-21	124	133	19	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	5.36e-20	137	133	19	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	3.56e-17	192	133	19	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L7 USP17L21 RELN USP17L4 USP17L2 USP17L12 USP17L1 ADAMTS4 ADAM23 USP17L20 USP17L11 PSMA6 USP17L24 USP17L5 USP17L10 USP17L19 ACE USP17L18 USP17L17 KLK8 USP17L6P USP17L3 ADAMTS18 ERVK-19 USP17L22 USP17L15 USP17L13	2.19e-14	654	133	27	GO:0008233
GeneOntologyMolecularFunction	ribosome binding	EIF1B SRP72 NOMO1 NOMO2 EIF1 NOMO3	1.53e-04	120	133	6	GO:0043022
GeneOntologyMolecularFunction	ribonucleoprotein complex binding	EIF1B SRP72 EZH2 NOMO1 NOMO2 EIF1 NOMO3	4.67e-04	206	133	7	GO:0043021
GeneOntologyMolecularFunction	growth factor binding	IGFBPL1 NRP2 IGF2R CSF1R SCN5A LTBP3	6.26e-04	156	133	6	GO:0019838
GeneOntologyMolecularFunction	histone H3K4me/H3K4me2/H3K4me3 demethylase activity	KDM5C KDM5D	6.49e-04	6	133	2	GO:0034647
GeneOntologyMolecularFunction	hyaluronic acid binding	USP17L24 SUSD5 USP17L6P	9.30e-04	29	133	3	GO:0005540
GeneOntologyMolecularFunction	histone H3K4 demethylase activity	KDM5C KDM5D	1.20e-03	8	133	2	GO:0032453
GeneOntologyMolecularFunction	nuclear androgen receptor binding	CALR KDM5D PRMT2	1.36e-03	33	133	3	GO:0050681
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.26e-21	125	128	19	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	3.69e-20	144	128	19	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L7 USP17L21 USP17L4 AMER1 USP17L2 USP17L12 USP17L1 USP17L20 MARCHF8 USP17L11 USP17L24 USP17L5 PELI2 USP17L10 PSMD10 USP17L19 PCMTD1 TRIM7 USP17L18 FBXL7 TULP4 USP17L17 USP17L6P USP17L3 TNKS2 USP17L22 USP17L15 USP17L13	1.73e-11	1009	128	28	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L7 USP17L21 USP17L4 AMER1 USP17L2 USP17L12 USP17L1 USP17L20 MARCHF8 USP17L11 USP17L24 USP17L5 PELI2 USP17L10 PSMD10 USP17L19 PCMTD1 TRIM7 USP17L18 FBXL7 TULP4 USP17L17 USP17L6P USP17L3 TNKS2 USP17L22 USP17L15 USP17L13	7.40e-11	1074	128	28	GO:0043687
GeneOntologyBiologicalProcess	response to tetrachloromethane	CPT1A EZH2 IGF2R	2.31e-06	5	128	3	GO:1904772
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO1 NOMO2 NOMO3	1.91e-05	9	128	3	GO:0160063
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 CALR USP17L20 MARCHF8 USP17L11 VPS13C USP17L5 USP17L10 USP17L19 NOMO1 USP17L18 USP17L17 NOMO2 USP17L6P USP17L3 USP17L22 USP17L15 NOMO3 USP17L13	1.70e-06	1293	132	24	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 CALR USP17L20 MARCHF8 USP17L11 VPS13C USP17L5 USP17L10 USP17L19 NOMO1 USP17L18 USP17L17 NOMO2 USP17L6P USP17L3 USP17L22 USP17L15 NOMO3 USP17L13	1.84e-06	1299	132	24	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 CALR USP17L20 MARCHF8 USP17L11 VPS13C USP17L5 USP17L10 USP17L19 NOMO1 USP17L18 USP17L17 NOMO2 USP17L6P USP17L3 USP17L22 USP17L15 NOMO3 USP17L13	2.67e-06	1327	132	24	GO:0042175
GeneOntologyCellularComponent	extracellular matrix	FRAS1 RELN COL13A1 ADAMTS4 CALR ADAMTSL3 IGFBPL1 FBLN1 EYS FCGBP MEGF6 ADAMTS18 LTBP3 MUC2 MUC5AC OTOG	3.97e-06	656	132	16	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	FRAS1 RELN COL13A1 ADAMTS4 CALR ADAMTSL3 IGFBPL1 FBLN1 EYS FCGBP MEGF6 ADAMTS18 LTBP3 MUC2 MUC5AC OTOG	4.12e-06	658	132	16	GO:0030312
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO1 NOMO2 NOMO3	2.01e-05	9	132	3	GO:0160064
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO1 NOMO2 NOMO3	8.51e-05	14	132	3	GO:0072379
GeneOntologyCellularComponent	mucus layer	MUC2 MUC5AC	1.18e-04	3	132	2	GO:0070701
GeneOntologyCellularComponent	collagen-containing extracellular matrix	FRAS1 RELN COL13A1 ADAMTS4 CALR IGFBPL1 FBLN1 EYS MEGF6 LTBP3 MUC2	5.49e-04	530	132	11	GO:0062023
GeneOntologyCellularComponent	chromosome, telomeric region	ATRX MCM2 UPF1 EZH2 PPP1CB TNKS2	8.92e-04	176	132	6	GO:0000781
GeneOntologyCellularComponent	pericentric heterochromatin	ATRX EZH2 DNMT1	1.07e-03	32	132	3	GO:0005721
MousePheno	increased trophectoderm apoptosis	USP17L2 USP17L15 USP17L13	1.11e-05	8	83	3	MP:0012119
MousePheno	increased embryonic tissue cell apoptosis	FRAS1 AMER1 USP17L2 USP17L15 DNMT1 USP17L13 MPI	3.39e-05	153	83	7	MP:0013504
Domain	HABP4_PAI-RBP1	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	3.61e-29	16	130	14	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	3.61e-29	16	130	14	IPR006861
Domain	UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	5.42e-22	71	130	17	PF00443
Domain	USP_2	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	5.42e-22	71	130	17	PS00973
Domain	USP_3	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	7.05e-22	72	130	17	PS50235
Domain	USP_dom	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	7.05e-22	72	130	17	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	7.05e-22	72	130	17	IPR001394
Domain	USP_CS	USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	7.48e-21	66	130	16	IPR018200
Domain	USP_1	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	2.12e-20	70	130	16	PS00972
Domain	VWC_out	FRAS1 JAG2 FCGBP MUC2 MUC5AC OTOG	2.55e-09	19	130	6	SM00215
Domain	VWF_dom	FRAS1 JAG2 FCGBP MUC2 MUC5AC OTOG	4.33e-07	42	130	6	IPR001007
Domain	C8	FCGBP MUC2 MUC5AC OTOG	1.06e-06	12	130	4	PF08742
Domain	TIL	FCGBP MUC2 MUC5AC OTOG	1.06e-06	12	130	4	PF01826
Domain	DUF2012	NOMO1 NOMO2 NOMO3	1.31e-06	4	130	3	PF09430
Domain	DUF2012	NOMO1 NOMO2 NOMO3	1.31e-06	4	130	3	IPR019008
Domain	Unchr_dom_Cys-rich	FCGBP MUC2 MUC5AC OTOG	1.53e-06	13	130	4	IPR014853
Domain	C8	FCGBP MUC2 MUC5AC OTOG	1.53e-06	13	130	4	SM00832
Domain	TIL_dom	FCGBP MUC2 MUC5AC OTOG	2.13e-06	14	130	4	IPR002919
Domain	VWF_type-D	FCGBP MUC2 MUC5AC OTOG	3.82e-06	16	130	4	IPR001846
Domain	VWFD	FCGBP MUC2 MUC5AC OTOG	3.82e-06	16	130	4	PS51233
Domain	VWD	FCGBP MUC2 MUC5AC OTOG	3.82e-06	16	130	4	SM00216
Domain	VWD	FCGBP MUC2 MUC5AC OTOG	3.82e-06	16	130	4	PF00094
Domain	VWC	FRAS1 JAG2 FCGBP MUC2 MUC5AC	6.31e-06	38	130	5	SM00214
Domain	EGF-like_dom	FRAS1 RELN ADAM23 JAG2 FBLN1 EYS FCGBP MEGF6 LTBP3 OTOG	9.73e-06	249	130	10	IPR000742
Domain	CT	NBL1 MUC2 MUC5AC OTOG	1.49e-05	22	130	4	SM00041
Domain	Carb-bd-like_fold	NOMO1 NOMO2 NOMO3	1.80e-05	8	130	3	IPR013784
Domain	Cys_knot_C	NBL1 MUC2 MUC5AC OTOG	2.53e-05	25	130	4	IPR006207
Domain	CTCK_2	NBL1 MUC2 MUC5AC OTOG	2.53e-05	25	130	4	PS01225
Domain	EGF	FRAS1 RELN ADAM23 JAG2 FBLN1 EYS FCGBP MEGF6 LTBP3	3.99e-05	235	130	9	SM00181
Domain	hEGF	JAG2 EYS MEGF6 LTBP3	4.03e-05	28	130	4	PF12661
Domain	SUI1_euk	EIF1B EIF1	4.81e-05	2	130	2	IPR005874
Domain	CarboxyPept_regulatory_dom	NOMO1 NOMO2 NOMO3	8.96e-05	13	130	3	IPR014766
Domain	-	NOMO1 NOMO2 NOMO3	8.96e-05	13	130	3	2.60.40.1120
Domain	Growth_fac_rcpt_	FRAS1 IGFBPL1 JAG2 FBLN1 EYS MEGF6 LTBP3	1.11e-04	156	130	7	IPR009030
Domain	VWFC_1	FRAS1 JAG2 MUC2 MUC5AC	1.11e-04	36	130	4	PS01208
Domain	VWFC_2	FRAS1 JAG2 MUC2 MUC5AC	1.38e-04	38	130	4	PS50184
Domain	CarboxyPept-like_regulatory	NOMO1 NOMO2 NOMO3	2.09e-04	17	130	3	IPR008969
Domain	EGF_3	RELN ADAM23 JAG2 FBLN1 EYS MEGF6 LTBP3 OTOG	2.43e-04	235	130	8	PS50026
Domain	-	EIF1B EIF1	2.86e-04	4	130	2	3.30.780.10
Domain	Lys_sp_deMease-like_dom	KDM5C KDM5D	2.86e-04	4	130	2	IPR013637
Domain	SUI1	EIF1B EIF1	2.86e-04	4	130	2	PF01253
Domain	PLU-1	KDM5C KDM5D	2.86e-04	4	130	2	PF08429
Domain	SUI1	EIF1B EIF1	2.86e-04	4	130	2	PS50296
Domain	zf-C5HC2	KDM5C KDM5D	4.74e-04	5	130	2	PF02928
Domain	SUI1	EIF1B EIF1	4.74e-04	5	130	2	IPR001950
Domain	Znf_C5HC2	KDM5C KDM5D	4.74e-04	5	130	2	IPR004198
Domain	EGF_Ca-bd_CS	JAG2 FBLN1 EYS MEGF6 LTBP3	5.84e-04	97	130	5	IPR018097
Domain	Peptidase_M12B_ADAM-TS	ADAMTS4 ADAMTSL3 ADAMTS18	5.99e-04	24	130	3	IPR013273
Domain	EGF_CA	JAG2 FBLN1 EYS MEGF6 LTBP3	6.41e-04	99	130	5	PS01187
Domain	ASX_HYDROXYL	JAG2 FBLN1 EYS MEGF6 LTBP3	6.71e-04	100	130	5	PS00010
Domain	WxxW_domain	MUC2 MUC5AC	7.08e-04	6	130	2	IPR025155
Domain	Mucin2_WxxW	MUC2 MUC5AC	7.08e-04	6	130	2	PF13330
Domain	EGF_extracell	RELN ADAM23 JAG2 MEGF6	8.08e-04	60	130	4	IPR013111
Domain	EGF_2	RELN ADAM23 JAG2 MEGF6	8.08e-04	60	130	4	PF07974
Domain	EGF-type_Asp/Asn_hydroxyl_site	JAG2 FBLN1 EYS MEGF6 LTBP3	8.74e-04	106	130	5	IPR000152
Domain	EGF_CA	JAG2 FBLN1 EYS MEGF6 LTBP3	1.64e-03	122	130	5	SM00179
Domain	EGF-like_Ca-bd_dom	JAG2 FBLN1 EYS MEGF6 LTBP3	1.76e-03	124	130	5	IPR001881
Domain	EGF_1	RELN ADAM23 JAG2 FBLN1 EYS MEGF6 LTBP3	2.07e-03	255	130	7	PS00022
Domain	JmjN	KDM5C KDM5D	2.09e-03	10	130	2	SM00545
Domain	JmjN	KDM5C KDM5D	2.09e-03	10	130	2	PF02375
Domain	JMJN	KDM5C KDM5D	2.09e-03	10	130	2	PS51183
Domain	JmjN	KDM5C KDM5D	2.09e-03	10	130	2	IPR003349
Domain	EGF-like_CS	RELN ADAM23 JAG2 FBLN1 EYS MEGF6 LTBP3	2.36e-03	261	130	7	IPR013032
Domain	Pep_M12B_propep	ADAMTS4 ADAM23 ADAMTS18	2.51e-03	39	130	3	PF01562
Domain	Peptidase_M12B_N	ADAMTS4 ADAM23 ADAMTS18	2.51e-03	39	130	3	IPR002870
Domain	EGF_2	RELN ADAM23 JAG2 FBLN1 EYS MEGF6 LTBP3	2.57e-03	265	130	7	PS01186
Domain	DISINTEGRIN_1	ADAMTS4 ADAM23 ADAMTS18	2.70e-03	40	130	3	PS00427
Domain	Reprolysin	ADAMTS4 ADAM23 ADAMTS18	2.70e-03	40	130	3	PF01421
Domain	ADAM_MEPRO	ADAMTS4 ADAM23 ADAMTS18	2.70e-03	40	130	3	PS50215
Domain	DISINTEGRIN_2	ADAMTS4 ADAM23 ADAMTS18	2.70e-03	40	130	3	PS50214
Domain	Peptidase_M12B	ADAMTS4 ADAM23 ADAMTS18	2.70e-03	40	130	3	IPR001590
Domain	Disintegrin_dom	ADAMTS4 ADAM23 ADAMTS18	2.90e-03	41	130	3	IPR001762
Domain	EGF_CA	JAG2 FBLN1 MEGF6 LTBP3	3.06e-03	86	130	4	PF07645
Domain	KRAB	ZNF473 ZNF850 ZNF836 ZNF33B ZNF37A ZNF257 ZNF347 ZNF506	3.61e-03	358	130	8	PS50805
Domain	KRAB	ZNF473 ZNF850 ZNF836 ZNF33B ZNF37A ZNF257 ZNF347 ZNF506	3.61e-03	358	130	8	PF01352
Domain	PLAC	ADAMTSL3 ADAMTS18	4.14e-03	14	130	2	PF08686
Domain	KRAB	ZNF473 ZNF850 ZNF836 ZNF33B ZNF37A ZNF257 ZNF347 ZNF506	4.33e-03	369	130	8	SM00349
Domain	KRAB	ZNF473 ZNF850 ZNF836 ZNF33B ZNF37A ZNF257 ZNF347 ZNF506	4.40e-03	370	130	8	IPR001909
Domain	-	KDM5C KDM5D	4.76e-03	15	130	2	1.10.150.60
Domain	BRIGHT	KDM5C KDM5D	4.76e-03	15	130	2	SM00501
Domain	ARID_dom	KDM5C KDM5D	4.76e-03	15	130	2	IPR001606
Domain	ARID	KDM5C KDM5D	4.76e-03	15	130	2	PS51011
Domain	ARID	KDM5C KDM5D	4.76e-03	15	130	2	PF01388
Domain	Sushi	CSMD2 CR1 SUSD5	5.68e-03	52	130	3	PF00084
Domain	CCP	CSMD2 CR1 SUSD5	6.31e-03	54	130	3	SM00032
Domain	CTCK_1	MUC2 MUC5AC	6.84e-03	18	130	2	PS01185
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	4.09e-28	45	98	18	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 PSMA6 USP17L5 USP17L10 PSMD10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 TNKS2 USP17L22 USP17L15 USP17L13	9.92e-20	191	98	21	MM15289
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 PSMA6 USP17L24 USP17L5 USP17L10 PSMD10 USP17L19 USP17L18 USP17L17 USP17L3 TNKS2 USP17L22 USP17L15 USP17L13	3.95e-17	221	98	20	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 PSMA6 USP17L5 USP17L10 PSMD10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 TNKS2 USP17L22 USP17L15 USP17L13	7.14e-17	262	98	21	MM15286
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 PSMA6 USP17L5 USP17L10 PSMD10 USP17L19 PPP1CB USP17L18 USP17L17 PIK3CA USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.71e-16	318	98	22	MM15278
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 PSMA6 USP17L24 USP17L5 USP17L10 PSMD10 USP17L19 USP17L18 USP17L17 USP17L3 TNKS2 USP17L22 USP17L15 USP17L13	1.39e-14	299	98	20	M27574
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 ADAMTS4 CALR USP17L20 USP17L11 PSMA6 USP17L5 USP17L10 PSMD10 USP17L19 ST6GALNAC6 ADAMTSL3 USP17L18 GCNT7 FBXL7 MEGF6 TULP4 USP17L17 USP17L6P USP17L3 ADAMTS18 TNKS2 USP17L22 MUC2 MUC5AC USP17L15 DNMT1 USP17L13 MPI	1.97e-11	1389	98	34	MM15307
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 USP17L4 AMER1 USP17L2 USP17L12 USP17L1 ADAMTS4 CALR USP17L20 USP17L11 PSMA6 USP17L24 USP17L5 USP17L10 PSMD10 USP17L19 ST6GALNAC6 ADAMTSL3 USP17L18 GCNT7 FBXL7 TULP4 USP17L17 USP17L3 ADAMTS18 TNKS2 USP17L22 MUC5AC USP17L15 DNMT1 USP17L13 MPI	2.08e-09	1475	98	32	M19806
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	ADAMTS4 ADAMTSL3 GCNT7 ADAMTS18 MUC2 MUC5AC	1.10e-04	109	98	6	MM15164
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.86e-41	21	136	18	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.86e-41	21	136	18	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.86e-41	21	136	18	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.86e-41	21	136	18	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.86e-41	21	136	18	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.86e-41	21	136	18	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.02e-40	22	136	18	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.87e-39	24	136	18	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	6.65e-39	25	136	18	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.16e-38	26	136	18	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	3.76e-38	33	136	19	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.50e-38	34	136	19	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.85e-37	35	136	19	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.85e-37	35	136	19	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	3.91e-37	36	136	19	20147298
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	4.73e-37	29	136	18	32527007
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.02e-37	37	136	19	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.31e-31	50	136	18	31806660
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L7 USP17L21 USP17L4 AMER1 USP17L2 USP17L12 USP17L1 ATRX USP17L20 USP17L11 USP17L5 NBL1 USP17L10 USP17L19 USP17L18 CORO2B ANKRD33 USP17L17 USP17L6P USP17L3 USP17L22 CEACAM20 USP17L15 USP17L13	2.06e-16	674	136	24	37196079
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	1.42e-15	10	136	7	24207026
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 DNMT1	3.23e-15	19	136	8	28067227
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	9.32e-15	12	136	7	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	4.01e-14	14	136	7	11793228
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	3.27e-08	81	136	7	12838346
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO1 NOMO2 NOMO3	5.85e-08	3	136	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO1 NOMO2 NOMO3	5.85e-08	3	136	3	25576386
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	2.33e-07	4	136	3	22984479
Pubmed	Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression.	JAG2 MUC2 MUC5AC	2.33e-07	4	136	3	22691042
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO1 NOMO2 NOMO3	2.33e-07	4	136	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO1 NOMO2 NOMO3	2.33e-07	4	136	3	9267806
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	4.66e-07	119	136	7	28625976
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO1 NOMO2 NOMO3	3.23e-06	8	136	3	15257293
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO1 NOMO2 NOMO3	4.83e-06	9	136	3	36261522
Pubmed	Hepatic lipase maturation: a partial proteome of interacting factors.	CALR NOMO1 NOMO2 NOMO3	6.48e-06	31	136	4	19136429
Pubmed	Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.	KDM5C KDM5D EZH2 DNMT1	8.38e-06	33	136	4	26864203
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO1 NOMO2 NOMO3	9.43e-06	11	136	3	32820719
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PLK2 RELN ZNF473 OXR1 ATRX ADAM23 SRPK2 ZNF836 CORO2B RSPH1 ARHGEF10 NOMO2 PRMT2 LTBP3 TNKS2 MTUS2 DNMT1	1.17e-05	1285	136	17	35914814
Pubmed	The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro.	SRPK1 SRPK2	1.52e-05	2	136	2	32817937
Pubmed	Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein.	SRPK1 SRPK2	1.52e-05	2	136	2	12134018
Pubmed	Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx.	KDM5C KDM5D	1.52e-05	2	136	2	10441747
Pubmed	EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition.	EZH2 PIK3CA	1.52e-05	2	136	2	34655667
Pubmed	Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus.	KDM5C KDM5D	1.52e-05	2	136	2	16416087
Pubmed	Mucolytic activity of bacterial and human chitinases.	MUC2 MUC5AC	1.52e-05	2	136	2	17321686
Pubmed	Mutations of histone demethylase genes encoded by X and Y chromosomes, Kdm5c and Kdm5d, lead to noncompaction cardiomyopathy in mice.	KDM5C KDM5D	1.52e-05	2	136	2	32081420
Pubmed	Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma.	MUC2 MUC5AC	1.52e-05	2	136	2	20731025
Pubmed	Genomic, Transcriptomic, Epigenetic, and Immune Profiling of Mucinous Breast Cancer.	PIK3CA MUC2	1.52e-05	2	136	2	30789657
Pubmed	The IgGFc-binding protein FCGBP is secreted with all GDPH sequences cleaved but maintained by interfragment disulfide bonds.	FCGBP MUC2	1.52e-05	2	136	2	34126068
Pubmed	Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein.	ATRX EZH2	1.52e-05	2	136	2	9499421
Pubmed	Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340).	SRPK1 SRPK2	1.52e-05	2	136	2	26244849
Pubmed	Studies of mucus in mouse stomach, small intestine, and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins.	MUC2 MUC5AC	1.52e-05	2	136	2	23832517
Pubmed	Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution.	MUC2 MUC5AC	1.52e-05	2	136	2	23832516
Pubmed	Expressed sequence tags identify a human isolog of the suil translation initiation factor.	EIF1B EIF1	1.52e-05	2	136	2	7904817
Pubmed	DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.	EZH2 DNMT1	1.52e-05	2	136	2	25595591
Pubmed	Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells.	EZH2 DNMT1	1.52e-05	2	136	2	26362062
Pubmed	A mouse Y chromosome gene encoded by a region essential for spermatogenesis and expression of male-specific minor histocompatibility antigens.	KDM5C KDM5D	1.52e-05	2	136	2	7524912
Pubmed	Intestinal MUC2 and gastric M1/MUC5AC in preneoplastic lesions induced by 1,2-dimethylhydrazine in rat: a sequential analysis.	MUC2 MUC5AC	1.52e-05	2	136	2	17203232
Pubmed	ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma.	ATRX EZH2	1.52e-05	2	136	2	32194873
Pubmed	Horizontal transfer of the stemness-related markers EZH2 and GLI1 by neuroblastoma-derived extracellular vesicles in stromal cells.	EZH2 GLI1	1.52e-05	2	136	2	34217898
Pubmed	Serine-arginine protein kinases: a small protein kinase family with a large cellular presence.	SRPK1 SRPK2	1.52e-05	2	136	2	21205200
Pubmed	A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4) cleaves Reelin in an isoform-dependent manner.	RELN ADAMTS4	1.52e-05	2	136	2	22819337
Pubmed	Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.	MUC2 MUC5AC	1.52e-05	2	136	2	12527922
Pubmed	PRMT2 and RORγ expression are associated with breast cancer survival outcomes.	PRMT2 RORC	1.52e-05	2	136	2	24911119
Pubmed	The possible role of EZH2 and DNMT1 polymorphisms in sporadic triple-negative breast carcinoma in southern Chinese females.	EZH2 DNMT1	1.52e-05	2	136	2	26162541
Pubmed	Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein.	FCGBP MUC2	1.52e-05	2	136	2	19432394
Pubmed	Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles.	SRPK1 SRPK2	1.52e-05	2	136	2	9446799
Pubmed	Inhibition of hepatitis C virus replication by a specific inhibitor of serine-arginine-rich protein kinase.	SRPK1 SRPK2	1.52e-05	2	136	2	20498328
Pubmed	In vivo glycosylation of mucin tandem repeats.	MUC2 MUC5AC	1.52e-05	2	136	2	11445551
Pubmed	Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer.	EZH2 PIK3CA	1.52e-05	2	136	2	28060766
Pubmed	Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven.	KDM5C KDM5D	1.52e-05	2	136	2	9060413
Pubmed	Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma.	MUC2 MUC5AC	1.52e-05	2	136	2	14594655
Pubmed	Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells.	EZH2 DNMT1	1.52e-05	2	136	2	19279403
Pubmed	Suppression of hepatitis B virus replication by SRPK1 and SRPK2 via a pathway independent of the phosphorylation of the viral core protein.	SRPK1 SRPK2	1.52e-05	2	136	2	16122776
Pubmed	Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide.	MUC2 MUC5AC	1.52e-05	2	136	2	12820724
Pubmed	Gli regulates MUC5AC transcription in human gastrointestinal cells.	GLI1 MUC5AC	1.52e-05	2	136	2	25166306
Pubmed	Single-cell profiling of epigenetic modifiers identifies PRDM14 as an inducer of cell fate in the mammalian embryo.	KDM5C EZH2 PRMT2 DNMT1	2.69e-05	44	136	4	24183668
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L7 USP17L4 USP17L1 USP17L3	3.81e-05	48	136	4	16421571
Pubmed	DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures.	RELN DNMT1	4.54e-05	3	136	2	15671176
Pubmed	Sodium butyrate induces differentiation of gastric cancer cells to intestinal cells via the PTEN/phosphoinositide 3-kinase pathway.	PIK3CA MUC2	4.54e-05	3	136	2	20718712
Pubmed	Differences in the expression of mucins in various forms of cystitis glandularis.	MUC2 MUC5AC	4.54e-05	3	136	2	17659847
Pubmed	Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas.	EZH2 DNMT1	4.54e-05	3	136	2	26892683
Pubmed	Identification of a second Grb2 binding site in the v-Fms tyrosine kinase.	CSF1R PIK3CA	4.54e-05	3	136	2	9380408
Pubmed	GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin.	GLI1 MUC5AC	4.54e-05	3	136	2	20972463
Pubmed	Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.	MUC2 MUC5AC	4.54e-05	3	136	2	18825309
Pubmed	SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease.	SRPK1 SRPK2	4.54e-05	3	136	2	23197718
Pubmed	Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer.	EZH2 DNMT1	4.54e-05	3	136	2	26305882
Pubmed	Insulin-like growth factor 2 receptor is an IFNgamma-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders.	IGF2R CSF1R	4.54e-05	3	136	2	20889566
Pubmed	Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.	MUC2 MUC5AC	4.54e-05	3	136	2	18300795
Pubmed	EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma.	EZH2 DNMT1	4.54e-05	3	136	2	30353102
Pubmed	Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast.	MUC2 MUC5AC	4.54e-05	3	136	2	17333267
Cytoband	4p16.1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.91e-21	79	135	14	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 FAM193A USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.11e-16	222	135	15	chr4p16
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L7 USP17L4 USP17L2 USP17L1 ARHGEF10 USP17L3	7.14e-05	234	135	6	chr8p23
Cytoband	8p23.1	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3	9.71e-05	154	135	5	8p23.1
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZFAT ZNF473 ZNF850 ZNF836 ZNF33B ZNF37A ZNF257 GLI1 ZNF347 ZNF506	4.21e-04	718	70	10	28
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 CR1 SUSD5	1.40e-03	57	70	3	1179
GeneFamily	AT-rich interaction domain containing	KDM5C KDM5D	1.50e-03	15	70	2	418
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS4 ADAMTS18	2.42e-03	19	70	2	50
GeneFamily	CD molecules\|Mucins	MUC2 MUC5AC	2.96e-03	21	70	2	648
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM5C KDM5D	3.86e-03	24	70	2	485
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 GLI1 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.34e-26	86	132	19	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 AS3MT USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	5.40e-24	112	132	19	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.97e-19	160	132	18	MM1155
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L7 USP17L21 USP17L4 TTC24 USP17L2 SPATA6 USP17L12 USP17L1 ACTRT3 USP17L20 USP17L11 KDM5C USP17L5 SRPK1 SRPK2 USP17L10 USP17L19 PPP1CB USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 GPN3 USP17L15 USP17L13	2.28e-11	1072	132	26	MM1031
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 TRIM7 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 GPN3 USP17L15 USP17L13	9.31e-11	647	132	20	MM981
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 ADAM23 USP17L20 USP17L11 USP17L5 MCM2 VTA1 USP17L10 PSMD10 USP17L19 EZH2 ZNF850 USP17L18 USP17L17 USP17L6P USP17L3 LTBP3 USP17L22 USP17L15 USP17L13	1.33e-09	1198	132	25	MM1062
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L7 USP17L21 PLK2 USP17L4 USP17L2 USP17L12 USP17L1 ADAMTS4 USP17L20 USP17L11 OGFOD2 USP17L5 USP17L10 USP17L19 TRIM7 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 GPN3 USP17L15 USP17L13	4.74e-08	1226	132	23	MM979
Coexpression	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	PLK2 NOMO1 PTPN14 IGF2R NOMO2 ANO3 NOMO3	4.37e-05	185	132	7	MM1115
Coexpression	NABA_MATRISOME	FRAS1 RELN COL13A1 ADAMTS4 ADAM23 OGFOD2 ADAMTSL3 IGFBPL1 FBLN1 EYS MEGF6 ADAMTS18 LTBP3 MUC2 MUC5AC OTOG	6.05e-05	1026	132	16	M5889
Coexpression	NABA_ECM_GLYCOPROTEINS	FRAS1 RELN IGFBPL1 FBLN1 EYS LTBP3 OTOG	6.29e-05	196	132	7	M3008
Coexpression	GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP	COL13A1 SRPK1 PPP1CB PHKG1 FBLN1 ZNF33B MUC2	6.50e-05	197	132	7	M5250
Coexpression	NABA_CORE_MATRISOME	FRAS1 RELN COL13A1 IGFBPL1 FBLN1 EYS LTBP3 OTOG	7.95e-05	275	132	8	M5884
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FRAS1 COL13A1 NBL1 ADAMTSL3 FBLN1 FBXL7 ANO3	1.36e-06	191	128	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FRAS1 COL13A1 NBL1 ADAMTSL3 FBLN1 FBXL7 ANO3	1.41e-06	192	128	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	FRAS1 COL13A1 ADAMTSL3 FBLN1 FBXL7 ANO3	1.69e-05	187	128	6	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 TRIM7 JAG2 PTPN14 FCGBP EIF1	1.69e-05	187	128	6	9c1013720c248ef201d010806b6e7ad24205e8ee
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 NBL1 PTPN14 SCN5A PRMT2 LTBP3	1.69e-05	187	128	6	806075c2531a7f5c1da38b85ea494a3b4b5e92ec
ToppCell	(2)_Fibroblasts-(22)_Fibro-3\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	RELN COL13A1 ADAM23 NBL1 ADCY7 FBLN1	1.85e-05	190	128	6	3aed03b87ba2c8d479048c3ceef3ff5e38746c28
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTS4 ADAMTSL3 FBLN1 CORO2B FBXL7 DNMT1	2.03e-05	193	128	6	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 ADAMTS4 ADAM23 NBL1 FBLN1 EIF1	2.15e-05	195	128	6	841fde528ecb293e07b5e00e499d1e9f0b0dce14
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ATRX VPS13C ARFGEF1 KDM5D TNKS2	2.15e-05	195	128	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ATRX VPS13C ARFGEF1 KDM5D TULP4	2.15e-05	195	128	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	ATRX VPS13C CR1 ADAMTSL3 CSF1R PIK3CA	2.34e-05	198	128	6	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	ATRX VPS13C CR1 ADAMTSL3 CSF1R PIK3CA	2.34e-05	198	128	6	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	ATRX VPS13C CR1 ADAMTSL3 CSF1R PIK3CA	2.34e-05	198	128	6	62cbf4b29e8af4983fb47a17f96da62682a5137e
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	7.38e-34	46	125	19	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	7.59e-30	69	125	19	DOID:1682 (implicated_via_orthology)
Disease	hepatocellular carcinoma (is_implicated_in)	CALR EZH2 ACE IGF2R CSF1R PIK3CA MTRR	1.26e-05	181	125	7	DOID:684 (is_implicated_in)
Disease	cystitis (is_marker_for)	MUC2 MUC5AC	1.78e-05	2	125	2	DOID:1679 (is_marker_for)
Disease	sputum mucin-5B amount	MUC2 MUC5AC	5.33e-05	3	125	2	OBA_2050332
Disease	sideroblastic anemia (is_implicated_in)	CALR ALAS2	5.33e-05	3	125	2	DOID:8955 (is_implicated_in)
Disease	syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology)	KDM5C KDM5D	1.06e-04	4	125	2	DOID:0060809 (implicated_via_orthology)
Disease	pancreatic ductal carcinoma (is_marker_for)	CALR ACE MUC5AC DNMT1	1.33e-04	61	125	4	DOID:3587 (is_marker_for)
Disease	mucinous adenocarcinoma (is_marker_for)	MUC2 MUC5AC	1.77e-04	5	125	2	DOID:3030 (is_marker_for)
Disease	response to platinum based chemotherapy, cytotoxicity measurement	FRAS1 EYS	1.77e-04	5	125	2	EFO_0004647, EFO_0006952
Disease	MYELODYSPLASTIC SYNDROME	ATRX CALR EZH2 CSF1R	1.91e-04	67	125	4	C3463824
Disease	chronic myeloid leukemia (is_marker_for)	EZH2 ACE DNMT1	2.02e-04	27	125	3	DOID:8552 (is_marker_for)
Disease	Primary Myelofibrosis	CALR EZH2	2.64e-04	6	125	2	C0001815
Disease	lung cancer (is_implicated_in)	CALR EZH2 ACE CSF1R	2.81e-04	74	125	4	DOID:1324 (is_implicated_in)
Disease	stomach cancer (is_marker_for)	CALR KDM5C EZH2 CSF1R PIK3CA	3.55e-04	142	125	5	DOID:10534 (is_marker_for)
Disease	Solid Neoplasm	EZH2 PIK3CA	3.69e-04	7	125	2	C0280100
Disease	liver cirrhosis (biomarker_via_orthology)	ACE MUC2 DNMT1	4.03e-04	34	125	3	DOID:5082 (biomarker_via_orthology)
Disease	Growth Disorders	ATRX PIK3CA LTBP3	4.78e-04	36	125	3	C0018273
Disease	myelofibrosis (is_implicated_in)	CALR EZH2	4.90e-04	8	125	2	DOID:4971 (is_implicated_in)
Disease	colorectal cancer (is_marker_for)	AMER1 CALR KDM5C EZH2 GLI1	5.62e-04	157	125	5	DOID:9256 (is_marker_for)
Disease	lung cancer (is_marker_for)	CALR CSF1R DNMT1	6.07e-04	39	125	3	DOID:1324 (is_marker_for)
Disease	HEPATOCELLULAR CARCINOMA	IGF2R PIK3CA	6.29e-04	9	125	2	114550
Disease	bringing up phlegm, sputum or mucus on most days, self-reported	MUC2 MUC5AC	6.29e-04	9	125	2	EFO_0009824
Disease	Hepatocellular carcinoma	IGF2R PIK3CA	6.29e-04	9	125	2	cv:C2239176
Disease	Acute Confusional Senile Dementia	RELN CR1 ACE IGF2R	8.47e-04	99	125	4	C0546126
Disease	Alzheimer's Disease, Focal Onset	RELN CR1 ACE IGF2R	8.47e-04	99	125	4	C0750900
Disease	Alzheimer Disease, Early Onset	RELN CR1 ACE IGF2R	8.47e-04	99	125	4	C0750901
Disease	Presenile dementia	RELN CR1 ACE IGF2R	8.47e-04	99	125	4	C0011265
Disease	Alzheimer Disease, Late Onset	RELN CR1 ACE IGF2R	8.47e-04	99	125	4	C0494463
Disease	schizophrenia (is_marker_for)	RELN ACE DNMT1	8.66e-04	44	125	3	DOID:5419 (is_marker_for)
Disease	Familial Alzheimer Disease (FAD)	RELN CR1 ACE IGF2R	8.79e-04	100	125	4	C0276496
Disease	Alzheimer's Disease	RELN CR1 ACE IGF2R	9.13e-04	101	125	4	C0002395
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	ACE PIK3CA	9.55e-04	11	125	2	DOID:0110861 (biomarker_via_orthology)
Disease	Neuroblastoma	ATRX DOCK8 PTPN14	1.05e-03	47	125	3	C0027819
Disease	Hematologic Neoplasms	CALR CSF1R	1.14e-03	12	125	2	C0376545
Disease	arachidonoylcarnitine (C20:4) measurement	MARCHF8 CPT1A	1.14e-03	12	125	2	EFO_0800544
Disease	acute myeloid leukemia (is_marker_for)	CALR EZH2 DNMT1	1.19e-03	49	125	3	DOID:9119 (is_marker_for)
Disease	Glioblastoma Multiforme	ATRX SRPK2 JAG2 PIK3CA	1.30e-03	111	125	4	C1621958
Disease	drug use measurement, depressive symptom measurement, SSRI use measurement	CSMD2 RORC	1.35e-03	13	125	2	EFO_0007006, EFO_0007010, EFO_0007011
Disease	dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement	MARCHF8 CPT1A	1.35e-03	13	125	2	EFO_0800547
Disease	phosphatidylcholine 40:7 measurement	ADAM23 NOMO1	1.35e-03	13	125	2	EFO_0021477
Disease	Carcinoma, Granular Cell	ACE PIK3CA MUC2 DNMT1	1.52e-03	116	125	4	C0205644
Disease	Adenocarcinoma, Tubular	ACE PIK3CA MUC2 DNMT1	1.52e-03	116	125	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	ACE PIK3CA MUC2 DNMT1	1.52e-03	116	125	4	C0205642
Disease	Carcinoma, Cribriform	ACE PIK3CA MUC2 DNMT1	1.52e-03	116	125	4	C0205643
Disease	Adenocarcinoma, Basal Cell	ACE PIK3CA MUC2 DNMT1	1.52e-03	116	125	4	C0205641
Disease	Adenocarcinoma	ACE PIK3CA MUC2 DNMT1	1.52e-03	116	125	4	C0001418
Disease	Diffuse Large B-Cell Lymphoma	EZH2 PIK3CA GLI1	1.66e-03	55	125	3	C0079744
Disease	Alzheimer disease, family history of Alzheimer’s disease	ADAMTS4 CR1 ACE CEACAM20	1.67e-03	119	125	4	EFO_0009268, MONDO_0004975
Disease	idiopathic pulmonary fibrosis	ACTRT3 PTPN14 MUC5AC	1.84e-03	57	125	3	EFO_0000768
Disease	colon cancer (is_marker_for)	CALR KDM5C EZH2	2.03e-03	59	125	3	DOID:219 (is_marker_for)
Disease	syndromic intellectual disability (implicated_via_orthology)	KDM5C KDM5D	2.05e-03	16	125	2	DOID:0050888 (implicated_via_orthology)
Disease	lung small cell carcinoma (is_marker_for)	ATRX CSF1R	2.05e-03	16	125	2	DOID:5409 (is_marker_for)
Disease	Dementia	CSF1R DNMT1	2.32e-03	17	125	2	C0497327
Disease	pre-malignant neoplasm (biomarker_via_orthology)	GLI1 MUC2	2.32e-03	17	125	2	DOID:0060071 (biomarker_via_orthology)
Disease	age-related hearing impairment	PSMA6 CDH23 VTA1 ADAMTSL3 PTPN14 GPBP1L1	2.63e-03	324	125	6	EFO_0005782
Disease	anorectal malformation	CSMD2 SUSD5	2.90e-03	19	125	2	MONDO_0019938
Disease	severe acute respiratory syndrome, COVID-19	RELN ADAM23 VTA1 GCNT7 EYS MEGF6 LTBP3	3.01e-03	447	125	7	EFO_0000694, MONDO_0100096
Disease	respiratory system disease	ADAMTSL3 RORC MUC2 MUC5AC	3.42e-03	145	125	4	EFO_0000684
Disease	family history of Alzheimer’s disease	ADAMTS4 CR1 CEACAM20	3.44e-03	71	125	3	EFO_0009268
Disease	Psychoses, Drug	CALR ACE	3.55e-03	21	125	2	C0033937
Disease	stomach cancer (is_implicated_in)	EZH2 ACE PIK3CA	3.58e-03	72	125	3	DOID:10534 (is_implicated_in)
Disease	intellectual disability (implicated_via_orthology)	ATRX KDM5C KDM5D	4.01e-03	75	125	3	DOID:1059 (implicated_via_orthology)
Disease	autism spectrum disorder (implicated_via_orthology)	KDM5C KDM5D NRP2 ARHGEF10	4.05e-03	152	125	4	DOID:0060041 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
DFRDEIKVYQQHCGG	ERICH3	306	Q5RHP9
AQGYKDHDLDLCVPI	BEST2	261	Q8NFU1
AEEENVGLHVPCGYL	ARHGEF10	136	O15013
CGYIPANHVGKHVDE	PRMT2	76	P55345
DSGQCPPNLHKQDGY	ADAM23	576	O75077
NHECIYSIQTQPGKG	CSMD2	1121	Q7Z408
TYGHCDQNGEEPFVK	CCDC7	101	Q96M83
CGQYLDDPDLKYGQH	DNMT1	356	P26358
HEALCKEAGYEGPLH	ACE	541	P12821
KEAGYEGPLHQCDIY	ACE	546	P12821
EGYCLPHGVQQLDLA	ACTRT3	166	Q9BYD9
IGDHFNKVGCNPNED	ARFGEF1	1191	Q9Y6D6
IHGLQRNDTGPYACE	CEACAM20	311	Q6UY09
AHGYVGADLKVLCNE	SPATA5	556	Q8NB90
LGYAEDGHCKGDINP	CPT1A	496	P50416
RDGEGKCEENPEFHN	AMER1	816	Q5JTC6
LDCDNDNKPGIGHIF	CCDC144CP	351	Q8IYA2
KFACNGTVIEHPEYG	EIF1B	66	O60739
KAYEVEDGHGQQRDP	ADCY7	426	P51828
GNEEKNFHLQPDGCL	CDH23	2771	Q9H251
GHRCENGVYDPQQDD	FAM193A	746	P78312
AGCLVDEPKQAGQYK	ADAMTS18	491	Q8TE60
ANHVEPSENCLKGYV	ANO3	851	Q9BYT9
EQEGKAAQEGYLGCH	MTUS2	321	Q5JR59
AAQEGYLGCHKEENL	MTUS2	326	Q5JR59
GCVYHVQLKAEGNDH	NOMO3	1011	P69849
SHCPFLDVNQQDKGG	ANKRD33	151	Q7Z3H0
CKPGDEIELTGIYHN	MCM2	406	P49736
GCVYHVQLKAEGNDH	NOMO2	1011	Q5JPE7
VVKYAPGQDLELGCH	OGFOD2	221	Q6N063
PGQDLELGCHYDNAE	OGFOD2	226	Q6N063
GKPCSYEGHVFQDGE	FRAS1	156	Q86XX4
HGICQDKGPAQFEYV	EYS	466	Q5T1H1
CNEYGQEKIEPGSLN	RPS6KC1	516	Q96S38
EPKENGEEGCHQNGL	GPBP1L1	356	Q9HC44
PDGYSGRNCEKAEHA	JAG2	336	Q9Y219
LQENGHIYVCGDAKN	MTRR	641	Q9UBK8
ICGAYGENTLNGHEK	KRT38	91	O76015
IQNGDHYPCLDDLEG	KDM5D	1026	Q9BY66
KFACNGTVIEHPEYG	EIF1	66	P41567
DNKPCGPQCYQHLEG	EZH2	316	Q15910
GPQCYQHLEGAKEFA	EZH2	321	Q15910
DRIYCGAGVQKDHEN	PCMTD1	161	Q96MG8
ESKGVCVHGNAEYQP	MUC2	4921	Q02817
LEHDPLQVGEGDCKY	NRP2	196	O60462
GCVYHVQLKAEGNDH	NOMO1	1011	Q15155
NPLRKEDEGVYQCHA	IGFBPL1	231	Q8WX77
TEPNFENKHGYGICH	MARCHF8	256	Q5T0T0
LEHYGQVQVKPEQGC	GLI1	806	P08151
CANGYPAVKVADQDG	MUC5AC	4896	P98088
QACGKEPSHEGLSVY	NBL1	121	P41271
FYHGLNLDDGKEDPC	OVOS2	611	Q6IE36
EANVPHAYLKGDCVE	MPI	271	P34949
KILPGCEIYSDAGNH	ALAS2	271	P22557
YHGGEPLCDNVNTQR	PIK3CA	361	P42336
DQGYQGTECHPEAAL	RELN	1051	P78509
APLKICGDIHGQYTD	PPP1CB	56	P62140
KNDPLVQENGCEEYG	OXR1	246	Q8N573
KNVPNCGRGYHLNEE	FBLN1	336	P23142
HKDGPLGETVLECYN	UPF1	171	Q92900
KGADCQEVPQDKDGY	ATRX	601	P46100
LDNGYGHCLLDKPEA	ADAMTS4	416	O75173
QDPEGGVDYKNIHLE	CSF1R	691	P07333
GHVEDDYILFDCPGQ	GPN3	96	Q9UHW5
YGKVANREHCFDGIP	CORO2B	21	Q9UQ03
KVLQQGEIGDCAEPY	DOCK8	351	Q8NF50
GHCKAIYPFDGHNEG	FNBP1L	541	Q5T0N5
YQCHTGPDGEQLFEL	CR1	1546	P17927
EEGNVHDGCKGRYVE	GCNT7	346	Q6ZNI0
CEGITDHGVEYLAKN	FBXL7	386	Q9UJT9
GLCGNYNQDPADDLK	FCGBP	4611	Q9Y6R7
TVKHEQNIDCGGGYV	CALR	96	P27797
CQVIYNGGITGHEKE	AS3MT	271	Q9HBK9
EFHSLCPDGKGYTQD	LTBP3	966	Q9NS15
TQYGEEENCHPRGEK	GPR156	341	Q8NFN8
QKKCEDAYPGQITDG	KLK8	181	O60259
PYDEDFNHEPCQRKG	C19orf54	216	Q5BKX5
QKGEKGQCGEYPHRE	COL13A1	206	Q5TAT6
LDCDNDNKPGIGHIF	CCDC144A	401	A2RUR9
LEGGANPDAKDHYEA	PSMD10	126	O75832
THGLCGNNNADPKDD	OTOG	281	Q6ZRI0
IECSMNEDHPGYGKE	PHKG1	196	Q16816
AQKENHTYEGACPID	RP1	1316	P56715
HVGYQLAADGKACED	MEGF6	271	O75095
GTGDPEHYLINVCKS	IGF2R	1396	P11717
YGLVQACGKDEAEAH	SUSD5	191	O60279
PHAELDAKGQGCTAY	PIH1D1	106	Q9NWS0
PKDCFIIYQGHHGDV	NDUFS1	561	P28331
GSKYCADQQPENHEV	RIMOC1	221	A6NDU8
QEEHCAPNKEPVKYG	PELI2	6	Q9HAT8
GQEIFPVKDNHGNCV	PTPN14	216	Q15678
PEGYRCLKAGENPDH	SCN5A	336	Q14524
PKGPDECVTYIQNEH	ST6GALNAC6	286	Q969X2
PGKYVFDVGCEQHGE	RSPH1	171	Q8WYR4
QEDPNDYCKGGYHLV	SRPK1	56	Q96SB4
PENLGLQEGTHELCY	SRP72	166	O76094
GGEIPGDTCDKYHEQ	TACR3	276	P29371
AHVNPADGGCLLEKY	C11orf54	131	Q9H0W9
PRENHYGNECGENIF	ZNF37A	196	P17032
IGIDEEQGPQVYKCD	PSMA6	141	P60900
VKPEELNGENAYHCG	USP17L3	241	A6NCW0
NEPYQKLATCDADGG	TULP4	91	Q9NRJ4
KHPNEEYANVGTGEL	ZFAT	1016	Q9P243
GQHGEPFKLYCQDDG	TRIM7	131	Q9C029
VPVKHYDCGESGNNF	ZNF33B	296	Q06732
GACYQALGQPELAAH	TTC24	161	A2A3L6
VKPEELNGENAYHCG	USP17L4	241	A6NCW7
NGASCHLEYSPERGK	RORC	196	P51449
YIHNCLKNGETPQAG	VTA1	151	Q9NP79
EQEDPADYCKGGYHP	SRPK2	56	P78362
VKPEELNGENAYHCG	USP17L18	241	D6R9N7
AKPEELNGENAYHCG	USP17L5	241	A8MUK1
VCHPKDIYATDQEGN	ZNF654	731	Q8IZM8
VKPEELNGENAYHCG	USP17L21	241	D6R901
VKPEELNGENAYHCG	USP17L13	241	C9JLJ4
VKPEELNGENAYHCG	USP17L19	241	D6RCP7
KCHGQDGYPENFQGV	TEX13C	291	A0A0J9YWL9
YHPGDNRSCNQKEGS	TEX13C	306	A0A0J9YWL9
HDLLKDGCGQFPYDA	VPS13C	3031	Q709C8
VKPEELNGENAYHCG	USP17L1	241	Q7RTZ2
DKGDLVPLHNACSYG	TNKS2	241	Q9H2K2
KNTHGLEYQCRDAEG	ZNF347	136	Q96SE7
VKPEELNGENAYHCG	USP17L12	241	C9JPN9
VKPEELNGENAYHCG	USP17L24	241	Q0WX57
VKPKELNGENAYHCG	USP17L7	241	P0C7H9
EHKGDTNPREYAACG	ERVK-19	926	Q9WJR5
YLSPEVLNKQGHGCE	PLK2	246	Q9NYY3
VKPEELNGENAYHCG	USP17L6P	241	Q6QN14
VKPEELNGENAYHCG	USP17L22	241	D6RA61
VKPEELNGENAYHCG	USP17L15	241	C9J2P7
VKPEELNGENAYHCG	USP17L17	241	D6RBQ6
CQQPRGTFHLDDGEY	SPATA6	431	Q9NWH7
QNHTDEKPYDGKECG	ZNF850	721	A8MQ14
DECPVHKRGYNGLKQ	ZNF506	121	Q5JVG8
VKPEELNGENAYHCG	USP17L2	241	Q6R6M4
VKPEELNGENAYHCG	USP17L20	241	D6RJB6
IIHTGEKPYNCNEFG	ZNF836	686	Q6ZNA1
VKPEELNGENAYHCG	USP17L10	241	C9JJH3
LHAGEEPYKCNERGK	ZNF473	396	Q8WTR7
VKPEELNGENAYHCG	USP17L11	241	C9JVI0
IHAGENPNKYEECGK	ZNF257	536	Q9Y2Q1
KEQGIYECSVANHLG	ADAMTSL3	1256	P82987
NGDHYPCLDDLEGLV	KDM5C	1041	P41229